Jubilant Ingrevia
Ticker > Company >

Jubilant Ingrevia share price

Jubilant Ingrevia Ltd.

NSE: JUBLINGREA BSE: 543271 SECTOR: Chemicals  108k   370   114

765.00
-29.55 (-3.72%)
NSE: 20 Dec 04:02 PM

Price Summary

Today's High

₹ 809.05

Today's Low

₹ 760.55

52 Week High

₹ 885

52 Week Low

₹ 420

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 12185.01 Cr.

Enterprise Value

₹ 12994.74 Cr.

No. of Shares

15.93 Cr.

P/E

85.05

P/B

5.29

Face Value

₹ 1

Div. Yield

0.65 %

Book Value (TTM)

₹  144.61

CASH

₹ 19.52 Cr.

DEBT

₹ 829.25 Cr.

Promoter Holding

51.47 %

EPS (TTM)

₹  8.99

Sales Growth

-12.55%

ROE

7.4 %

ROCE

10.46%

Profit Growth

-35.9 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-12.55%
3 Year81.31%
5 YearNA

Profit Growth

1 Year-35.9%
3 Year61.47%
5 YearNA

ROE%

1 Year7.4%
3 Year15.03%
5 Year9.99%

ROCE %

1 Year10.46%
3 Year18.92%
5 Year12.47%

Debt/Equity

0.3706

Price to Cash Flow

30.95

Interest Cover Ratio

4.6052

CFO/PAT (5 Yr. Avg.)

1.68802783342305

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 51.47 2.71
Jun 2024 51.47 2.71
Mar 2024 51.47 3.45
Dec 2023 51.47 3.45
Sep 2023 51.47 3.45
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 61.4683347434085% for the Past 3 years.
  • The company has shown a good revenue growth of 81.3129162880008% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -9.0283 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.68802783342305.
  • The company has a high promoter holding of 51.47%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.55257487340699.

 Limitations

  • The company is trading at a high PE of 85.05.
  • The company is trading at a high EV/EBITDA of 30.9715.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 1003.09 916.7 1036.74 969.09 1005.39
Total Expenditure 882.15 842.7 942.91 880.95 877.52
Operating Profit 120.94 74 93.83 88.14 127.87
Other Income 8.03 8.11 9.77 9.22 8.96
Interest 15.9 18.46 16.65 16.69 17.31
Depreciation 33.29 33.64 34.52 36.33 37.02
Exceptional Items 0 0 0 0 0
Profit Before Tax 79.78 30.01 52.43 44.34 82.5
Tax 22.46 10.68 21.45 11.57 22.32
Profit After Tax 57.32 19.33 30.98 32.77 60.18
Adjusted EPS (Rs) 3.6 1.21 1.94 2.06 3.78

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 668.93 4860.42 4559.58 3987.25
Total Expenditure 0.17 572.1 4047.4 4065.04 3584.33
Operating Profit -0.17 96.83 813.02 494.53 402.92
Other Income 0 2.45 28.82 31.03 35.52
Interest 0 9.45 46.24 38.24 66.29
Depreciation 0 21.35 120.13 119.74 133.14
Exceptional Items 0 -12.94 0 0 0
Profit Before Tax -0.17 55.54 675.47 367.58 239
Tax 0 16.95 223.22 114.17 76.55
Net Profit -0.17 38.59 452.25 253.41 162.45
Adjusted EPS (Rs.) -3.32 2.42 28.39 15.91 10.2

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.05 15.93 15.93 15.93 15.93
Total Reserves -0.17 1559.92 1967.12 2142.65 2231.13
Borrowings 0 646.83 295.68 337.25 395.57
Other N/C liabilities 0 136.63 242.43 293.17 309.68
Current liabilities 0.17 880.66 1130.97 1269.4 1388.09
Total Liabilities 0.05 3239.97 3652.13 4058.39 4340.4
Assets
Net Block 0 1726.83 1727.58 1775.42 2291.66
Capital WIP 0 62.91 161.71 476.52 180.33
Intangible WIP 0 1.91 4.96 0 0.68
Investments 0 134.89 139.19 171.89 296.97
Loans & Advances 0 17.9 20.78 32.72 11.51
Other N/C Assets 0 0.5 13.02 4.66 16.17
Current Assets 0.05 1295.02 1584.89 1597.19 1543.08
Total Assets 0.05 3239.97 3652.13 4058.39 4340.4
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.17 55.54 675.47 367.58 239
Adjustment 0 46.99 178.75 159.61 210.89
Changes in Assets & Liabilities 0.17 12.24 -156.3 -9.89 -23
Tax Paid 0 -10.59 -111.12 -71.67 -33.24
Operating Cash Flow 0 104.18 586.8 445.64 393.65
Investing Cash Flow 0 31.67 -220.76 -475.28 -463.67
Financing Cash Flow 0.05 -70.2 -410.23 32.8 64.07
Net Cash Flow 0.05 65.64 -44.19 3.16 -5.95

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 51.47 51.47 51.47 51.47 51.47
hari shanker bhartia 0.23 0.23 0.23 0.23 0.23
hsb trustee company pl & ... 19.00 19.00 19.00 19.00 19.00
jubilant enpro private li... 1.77 1.77 1.77 1.77 1.77
kavita bhartia 0.01 0.01 0.01 0.01 0.01
mav management advisors l... 3.15 3.15 3.15 3.15 3.15
miller holdings pte ltd 3.53 3.53 3.53 3.53 3.53
nikita resources private ... 2.20 2.20 2.20 2.20 2.20
priyavrat bhartia 0.88 0.88 0.88 0.88 0.88
shamit bhartia 0.08 0.08 0.08 0.08 0.08
spb trustee company pl & ... 20.63 20.63 20.63 20.63 20.63
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 48.53 48.53 48.53 48.53 48.53
aditya birla sun life ins... - - 1.42 1.18 1.06
dsp small cap fund 6.30 8.23 9.10 9.20 9.50
investor education and pr... - - 1.24 1.24 1.24
llp - - - - 0.12
rekha jhunjhunwala 3.12 3.12 3.10 3.06 2.97
investor education and pr... 1.24 1.24 - - -
nippon life india trustee... 1.30 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Jubilant Ingrevia informs about postal ballot notice 21 Dec, 3:09 PM Jubilant Ingrevia raises Rs 100 crore through commercial papers 12 Dec, 11:57 AM Jubilant Ingrevia informs about presentation 22 Oct, 5:05 PM Jubilant Ingrevia informs about superannuation of co-CEO & whole-time director 22 Oct, 5:04 PM Jubilant Ingrevia informs about appointment of CEO and managing director 22 Oct, 5:00 PM Jubilant Ingrevia informs about outcome of board meeting 22 Oct, 2:55 PM Jubilant Ingrevia - Quaterly Results 22 Oct, 2:17 PM Jubilant Ingrevia - Quaterly Results 22 Oct, 2:17 PM Jubilant Ingrevia - Quaterly Results 22 Oct, 2:17 PM Jubilant Ingrevia’s arm inks pact to produce Agro Intermediate 3 Oct, 2:40 PM Jubilant Ingrevia raises Rs 100 crore through Commercial Papers 13 Sep, 11:44 AM Jubilant Ingrevia raises Rs 100 crore through Commercial Papers 25 Jul, 5:43 PM Jubilant Ingrevia - Quaterly Results 16 Jul, 3:21 PM Jubilant Ingrevia - Quaterly Results 16 Jul, 3:21 PM Jubilant Ingrevia - Quaterly Results 16 Jul, 3:21 PM Jubilant Ingrevia gets EIR from USFDA for manufacturing facility in Gujarat 27 Jun, 4:35 PM Jubilant Ingrevia informs about disclosure 4 Jun, 12:39 PM Jubilant Ingrevia raises Rs 100 crore through Commercial Papers 17 May, 12:11 PM Jubilant Ingrevia reports 44% fall in Q4 consolidated net profit 14 May, 3:51 PM Jubilant Ingrevia - Quaterly Results 14 May, 2:50 PM Jubilant Ingrevia - Quaterly Results 14 May, 2:50 PM Jubilant Ingrevia - Quaterly Results 14 May, 2:50 PM Jubilant Ingrevia informs about press release 1 Apr, 10:49 AM Jubilant Ingrevia commissions new facility for Diketene derivatives at Uttar Pradesh 1 Apr, 9:29 AM Jubilant Ingrevia inks pact with O2 Renewable Energy XVIII 12 Mar, 3:29 PM Jubilant Ingrevia commissions agro active & intermediate plant in Gujarat 5 Mar, 3:18 PM Jubilant Ingrevia raises Rs 50 crore through Commercial Papers 3 Feb, 10:59 AM Jubilant Ingrevia informs about outcome of board meeting 30 Jan, 5:10 PM Jubilant Ingrevia - Quaterly Results 30 Jan, 3:08 PM Jubilant Ingrevia - Quaterly Results 30 Jan, 3:08 PM Jubilant Ingrevia - Quaterly Results 30 Jan, 3:08 PM Jubilant Ingrevia’s arm purchases 6.67% stake in Forum I Aviation 27 Jan, 12:44 PM Jubilant Ingrevia informs about disclosure 11 Jan, 3:13 PM Jubilant Ingrevia commissions Mutipurpose Agro Intermediate Plant for Value Added Derivatives 1 Jan, 10:12 AM Jubilant Ingrevia informs about updates 15 Nov, 5:14 PM Jubilant Ingrevia - Quaterly Results 1 Nov, 1:16 PM Jubilant Ingrevia - Quaterly Results 1 Nov, 1:16 PM Jubilant Ingrevia - Quaterly Results 1 Nov, 1:16 PM Jubilant Ingrevia raises Rs 100 crore through Commercial Papers 26 Oct, 4:29 PM Jubilant Ingrevia raises Rs 100 crore through Commercial Papers 8 Sep, 5:50 PM Jubilant Ingrevia informs about outcome of board meeting 18 Aug, 1:19 PM Jubilant Ingrevia gets nod to raise Rs 600 crore via commercial papers 18 Aug, 12:20 PM Jubilant Ingrevia - Quaterly Results 26 Jul, 2:31 PM Jubilant Ingrevia - Quaterly Results 26 Jul, 2:31 PM Jubilant Ingrevia - Quaterly Results 26 Jul, 2:31 PM Jubilant Ingrevia raises Rs 125 crore through Commercial Papers 26 Jul, 10:00 AM Jubilant Ingrevia raises Rs 100 crore via commercial papers 27 May, 12:16 PM Jubilant Ingrevia - Quaterly Results 16 May, 2:09 PM Jubilant Ingrevia - Quaterly Results 16 May, 2:09 PM Jubilant Ingrevia - Quaterly Results 16 May, 2:09 PM

Jubilant Ingrevia Stock Price Analysis and Quick Research Report. Is Jubilant Ingrevia an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Jubilant Ingrevia stock price today is Rs 765. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Jubilant Ingrevia . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Jubilant Ingrevia has a PE ratio of 85.0548131017767 which is high and comparatively overvalued .

  • Share Price: - The current share price of Jubilant Ingrevia is Rs 765. One can use valuation calculators of ticker to know if Jubilant Ingrevia share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Jubilant Ingrevia has ROA of 3.8684 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Jubilant Ingrevia has a Current ratio of 1.1117 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Jubilant Ingrevia has a ROE of 7.3973 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Jubilant Ingrevia has a Debt to Equity ratio of 0.3706 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Jubilant Ingrevia has reported revenue growth of -12.5522 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Jubilant Ingrevia for the current financial year is 10.1050874926547 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Jubilant Ingrevia is Rs 5 and the yield is 0.6511 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Jubilant Ingrevia is Rs 8.9942 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Jubilant Ingrevia in Ticker for free. Also, one can get the intrinsic value of Jubilant Ingrevia by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Jubilant Ingrevia

Jubilant Ingrevia Ltd. Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis

Jubilant Ingrevia Ltd. is a leading speciality chemicals company in India that offers a broad range of high-value-added products, services, and solutions. This company is an attractive stock for long-term investors looking for potential investment opportunities. This Jubilant Ingrevia Ltd. stock analysis page provides an in-depth overview of various essential topics related to the company's financial performance and growth potential.

Jubilant Ingrevia Ltd. Share Price:

Analyzing the share price of Jubilant Ingrevia Ltd. is essential for long-term investors seeking potential investment opportunities in the stock market. By understanding the share price movement over time, investors can identify trends, compare performance with industry peers, and evaluate growth potential. Using our website's pre-built screening tools, investors can analyze Jubilant Ingrevia Ltd.'s share price trends more effectively. A range of factors, such as market sentiment, financial performance, and general economic conditions, determines a stock's share price.

Jubilant Ingrevia Ltd. Balance Sheet:

To gain a deep understanding of Jubilant Ingrevia Ltd.'s financial health and growth potential, analyzing its balance sheet is critical. The balance sheet provides insights into the company's liquidity, debt levels, and current ratio. Utilizing our pre-built screening tools, investors can compare Jubilant Ingrevia Ltd.'s balance sheet with industry peers and identify potential investing opportunities for long-term growth.

Jubilant Ingrevia Ltd. Annual Report:

Jubilant Ingrevia Ltd.'s annual reports are valuable resources for long-term investors seeking an understanding of the company's performance. Our website provides downloadable copies of the annual reports, allowing investors to delve into the information provided. By utilizing our premium features tools, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont Analysis, investors can gain deeper insights and make well-informed decisions about their long-term investment strategies.

Jubilant Ingrevia Ltd. Dividend:

Understanding Jubilant Ingrevia Ltd.'s dividend payout history is crucial for long-term stock investors seeking consistent returns. Assessing the consistency and growth potential of the company's dividend payouts is essential. Our website provides information on Jubilant Ingrevia Ltd.'s dividend payouts, allowing for analysis and comparison with industry peers. Utilizing our pre-built screening tools, investors can identify potential investment opportunities and make informed decisions about long-term investments.

Jubilant Ingrevia Ltd. Quarterly Result:

Analyzing Jubilant Ingrevia Ltd.'s quarterly results is vital for long-term investors seeking a comprehensive understanding of the company's performance over time. Our website offers quick access to detailed analysis of Jubilant Ingrevia Ltd.'s quarterly results, enabling investors to make well-informed decisions about long-term investments. Investors can also download Jubilant Ingrevia Ltd.'s quarterly reports from our website for a more in-depth analysis.

Jubilant Ingrevia Ltd. Stock Price:

Jubilant Ingrevia Ltd.'s stock price reflects the company's company's overall performanceand is a critical factor for long-term investors seeking potential investment opportunities. It is essential to analyse the trends in Jubilant Ingrevia Ltd.'s stock price over time and compare its performance with industry peers. Our pre-built screening tools enable quick analysis and identification of potential long-term investment opportunities. Our website provides pre-built screening tools to help investors analyze stock prices and performance.

Jubilant Ingrevia Ltd. Price Chart:

Graphical representation of Jubilant Ingrevia Ltd's stock price trends greatly benefits long-term investors seeking potential investment opportunities. By utilizing the price charts available on our website and combining them with our pre-built screening tools, investors can gain valuable insights into the company's performance and growth potential for long-term investments.

Jubilant Ingrevia Ltd. News:

Staying updated with the latest news and market developments is crucial for long-term stock investors. Our website features timely articles and events related to Jubilant Ingrevia Ltd.'s stock market performance. By tracking both local and international news, investors can gain valuable insights into the company's financial performance and growth potential, allowing for well-informed decisions about long-term investments.

Jubilant Ingrevia Ltd. Concall Transcripts:

Analyzing Jubilant Ingrevia Ltd.'s con call transcripts provides long-term investors with important insights into the company's future guidance, strategic initiatives, and financial performance. Our website provides access to Jubilant Ingrevia Ltd.'s con call transcripts as downloadable documents for in-depth analysis. By utilizing our premium feature tools, such as DCF Analysis and Earnings multiple approaches, investors can analyze the information provided in the transcripts and gain crucial insights.

Jubilant Ingrevia Ltd. Investor Presentations:

Jubilant Ingrevia Ltd.'s investor presentations offer investors vast amounts of information about the company's growth potential as a long-term investment opportunity. Our website provides access to Jubilant Ingrevia Ltd.'s investor presentations as downloadable documents, enhancing investors' analysis. By utilizing our premium feature tools, such as BVPS Analysis and DuPont Analysis, investors can analyze the information provided in the presentations and gain valuable insights.

Jubilant Ingrevia Ltd. Promoters and Shareholders:

Understanding the promoters and shareholders of Jubilant Ingrevia Ltd. is critical for long-term investors. Our website provides detailed information about the company's promoters and shareholders, facilitating in-depth analysis and informed decision-making. Utilize our pre-built screening tools to analyze Jubilant Ingrevia Ltd.'s shareholding patterns and identify potential long-term growth opportunities.

This Jubilant Ingrevia Ltd., stock analysis page, covers various critical areas of interest for long-term stock investors. From analyzing share price trends to understanding the balance sheet, annual reports, dividend payouts, and quarterly results, this page provides comprehensive insights for informed decision-making. Additionally, our website offers pre-built screening tools to compare and analyze Jubilant Ingrevia Ltd.'s performance with industry peers. Moreover, our premium feature tools like DCF Analysis, BVPS Analysis, Earnings multiple approaches, and DuPont Analysis enhance the analysis process. You can also access downloadable copies of Jubilant Ingrevia Ltd.'s annual reports and quarterly results for deeper analysis.

Read More
X